U.S. President Donald Trump has announced plans to implement a significant tariff on pharmaceutical imports, aiming to incentivize drug companies to move their operations back to the United States. The tariff could heavily affect India’s pharmaceutical exports, which play a vital role in the U.S. healthcare system. BulletsIn Trump confirmed plans to introduce a “major”











